Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16557325 | 0.95 | KDM4E (0.42) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL16557341 | 0.93 | KDM4E (0.44) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL14032393 | 0.93 | KDM4E (0.49) | KDM4EATML3MBTL1NPY5RHDAC6 | |
| SCHEMBL23450676 | 0.90 | KDM4E (0.45) | KDM4EATML3MBTL1HDAC6HDAC4 | |
| SCHEMBL23450862 | 0.88 | L3MBTL1 (0.45) | KDM4EATML3MBTL1HDAC6HDAC4 | |
| SCHEMBL2699413 | 0.88 | L3MBTL1 (0.55) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL29400144 | 0.88 | L3MBTL1 (0.55) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL13725862 | 0.88 | L3MBTL1 (0.55) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL134336 | 0.88 | L3MBTL1 (0.55) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL29364265 | 0.88 | L3MBTL1 (0.55) | KDM4EATML3MBTL1PTGER4TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200144517-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2020-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200144517-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | KDM4E 2960/4885ATM 1582/4885L3MBTL1 958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.